throughout the last 20 years, Franc...

throughout the last 20 years, France has become a major nave of the European biotechnology sector. The renewed French interest emerg from the perception that progres in biotechnology is advantageous not only for the country's economy on the contrary also for the well being of family worldwide and both the private and the public sectors. This realization has produc a cooperative and effective regulatory and fiscal environment. In particular, as of 2004 start-ups benefit from the "Innovative Startups" status. This fresh legislation allows full tax and social costlinesss exemptions for small and